Acta Scientific Medical Sciences (ASMS)(ISSN: 2582-0931)

Review Article Volume 6 Issue 4

Misinformation and COVID Vaccine Hesitancy: The Viral Threat to COVID Vaccine Efficacy

Moki Chris Usani*

Elizabeth Glaser Pediatric Aids Foundation, Ministry of Public Health, Biaka University Institute Buea, Cameroon

*Corresponding Author: Moki Chris Usani, Elizabeth Glaser Pediatric Aids Foundation, Ministry of Public Health, Biaka University Institute Buea, Cameroon.

Received: December 07, 2021; Published: March 10, 2022

Abstract

Not long after the corona virus introduced itself in Wuhan, China, with all the subtlety and finesse of a bull in a China shop, efforts towards creating and distributing a vaccine reached fever pitch. In fact, just a few months after the World Health Organization (WHO) declared COVID-19 a pandemic (on March 11, 2020), two major pharmaceutical and biotech giants: Pfizer (in partnership with BioNTech) and Moderna, Inc., announced their success following the primary efficacy analyses of their phase 3 COVID-19 vaccine trials.

Keywords: COVID-19; World Health Organization (WHO); Wuhan

References

  1. “U.S. Food and Drug Administration”. Maryland: FDA (2020).
  2. “U.S. Food and Drug Administration”. Maryland: FDA (2020).
  3. “U.S. Food and Drug Administration”. Maryland: FDA (2021).
  4. Zimmer C., et al. “Corona Virus Vaccine Tracker”. New York: New York Times (2021).
  5. MacDonald N E and SAGE Working Group on Vaccine Hesitancy. “Vaccine hesitancy: Definition, scope and determinants”. Vaccine34 (2015): 4161-4164.
  6. Coustasse Alberto., et al. “COVID-19 and Vaccine Hesitancy”. Journal of Ambulatory Care Management1 (2021): 71-75.
  7. org. “The History of Vaccines”. Philadelphia: An Educational Resource by the College of Physicians of Philadelphia (2018).
  8. McAteer J., et al. “The VACCINES Act: Deciphering Vaccine Hesitancy in the Time of COVID-19”. Clinical Infectious Diseases 15 (2020): 703-705.
  9. “U.S. Center for Disease Control”. Georgia: CDC (2021).
  10. “U.S. Center for Disease Control”. Georgia: CDC (2021).
  11. “U.S. Center for Disease Control”. Georgia: CDC (2021).
  12. “U.S. Center for Disease Control”. Georgia: CDC (2021).
  13. “U.S. Center for Disease Control”. Georgia: CDC (2021).
  14. Polack FP., et al. “Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine”. The New England Journal of Medicine 383 (2020): 2603-2615.
  15. “U.S. National Institute of Health”. Maryland: NIH (2021).
  16. “U.S. National Institute of Health”. Maryland: NIH (2020).
  17. “Moderna”. (2021).
  18. “U.S. Food and Drug Administration”. Maryland: FDA (2020).

Citation

Citation: Moki Chris Usani. “Misinformation and COVID Vaccine Hesitancy: The Viral Threat to COVID Vaccine Efficacy”.Acta Scientific Medical Sciences 6.4 (2022): 57-63.

Copyright

Copyright: © 2022 Moki Chris Usani. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.403

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2022.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US